Abstract
It was shown earlier that melatonin (MLT) inhibits spontaneous and chemically induced mammary carcinogenesis and transplantable mammary tumor growth in vivo and in vitro. We have studied the effect of MLT on colon carcinogenesis. Three-month-old male LIO rats were exposed to 5 or 15 weekly s.c. injections of 1,2-di-methylhydrazine (DMH, 21 mg/kg). Part of the DMH-treated rats were given MLT in tap water (20 µg/ml) at nighttime during the period of carcinogen treatment. Rats were sacrificed 6 months after the first DMH injection. The exposure to MLT was followed by a decrease of intestinal tumor incidence in the jejunum and ascending colon as compared to controls. MLT inhibits the multiplicity and size of colon tumors as well as increasing tumor differentiation. The levels of immunohistochemically detected MLT in epithelium of the intestinal tract of rats exposed to DMH were significantly reduced as compared to intact rats, while in rats treated with DMH + MLT it was within the range of the controls. In the serum of rats exposed to DMH alone, the levels of diene conjugates (DC) and Schiff’s bases (SB) were significantly increased as compared with controls. In colon tissue of DMH-treated rats, the levels of DC, SB, and carbonyl derivatives of amino acid NO-synthase activity were significantly increased, while total antioxidative activity was decreased as compared to controls. In rats exposed to DMH + MLT, a normalization of free radical processes in serum and colon has been observed. MLT also inhibits the mutagenic effect of DMH in vivo (chromosome aberration and sperm head anomalies tests) and in vitro (Ames test). MLT also exerts some normalizing influence on glucose and lipid metabolism in rats exposed to DMH and inhibits proliferation and stimulates apoptosis in DMH-induced colon tumors. Thus, our data have shown that MLT affects initiating, promoting, and progression stages of colon carcinogenesis.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Anisimov VN (1987) Carcinogenesis and Aging. Vols. 1 and 2. CRC Press, Boca Raton
Anisimov VN (1998) In: Balducci L, Lyman GH, Ershler BW (eds) Comprehensive Geriatric Oncology. Harwood Acad Publ, Amsterdam, pp 157–178
Anisimov VN, Reiter RJ (1990) Pineal function during cancer and ageing. Vopr Oncol 36: 259–268
Anisimov VN, Azarova MA, Dmitrievskaya AY, Likhachev A, Petrov AS (1976) Disssemination of H3-dialkylhydrazines in the neuroendocrine system and their antigonadotropic effect in rats. Bull Exp Biol Med 82: 1473–1475
Anisimov VN, Pozdeev VK, Dmitrievskaya AY, Gracheva GM, iPin AP (1976 a) Effect of the enterotropic carcinogen 1,2-dimethylhydrazine on the level of biogenic amines in the hypothalamus of rats. Bull Exp Biol Med 82: 1359–1361
Anisimov VN, Pozharisski KM, Dilman VM (1980) Effect of phenformin on blastomogenic effect of 1,2-dimethylhydrazine. Vopr Onkol 26: 54–58
Anisimov VN, Khavinson VKh, Morozov VG (1994) Twenty years of study on effects of pineal peptide preparation: epithalamin in experimental gerontology and oncology. Ann NY Acad Sci 719: 483–493
Anisimov VN, Khavinson VKh, Prokopenko VM (1995) Melatonin and epithalamin inhibit free radical oxidation in rats. Proc Russian Acad Sci 343: 557–559
Anisimov VN, Arutyunian AV, Khavinson VKh (1996) Melatonin and epithalamin inhibit the process of lipid peroxidation in rats. Proc Russian Acad Sci 348: 265–267
Anisimov VN, Zabezhinski MA, Popovich IG et al. (1996 a) Pineal hormone melatonin inhibits 1,2-dimethylhydrazine-induced colon carcinogenesis in rats: the role of free radical mechanisms. Int J Oncol 9 (Suppl): 834
Anisimov VN, Arutyunian AV, Khavinson VKh (1997) Effect of melatonin and epithalamin on the activity of the antioxidant defense system in rats. Proc Russian Acad Sci 352: 831–833
Anisimov VN, Popovich IG, Zabezhinski MA(1997a) Melatonin and colon carcinogenesis: I. Inhibitory effects of melatonin on development of intestinal tumors induced by 1,2-imethylhydrazine in rats. Carcinogenesis 18: 1549–1553
Anisimov VN, Kvetnoy IM, Chumakova NK, Kvetnaia TV, Molotkov AO, Pogudina NA, Popovich VV, Popuchiev VV, Zabezhinski MA, Bartsch H, Bartsch C (1999) Melatonin and colon carcinogenesis. II. Intestinal melatonin-containing cells and serum melatonin level in rats with 1,2-dimethylhydrazine-induced colon tumors. Exp Toxicol Pathol 51: 47–52
Anisimov VN, Popovich IG, Shtylik AV, Zabezhinski MA, Ben-Huh H, Gurevich P, Berman V, Tendler Y, Zusman I (2000) Melatonin and colon carcinogenesis. III. Effect of melatonin on proliferative activity and apoptosis in colon mucosa and colon tumors induced by 1,2-dimethylhydrazine in rats. Exp Toxicol Pathol 52: 71–76
Arutyunyan AV, Prokopenko VM, Burmistrov SO, Opatina TI, Frolova EV, Zabezhinskii MA, Popovich IG, Anisimov VN (1997) Free radical processes in serum, liver and colon during carcinogenesis induced by 1,2-dimethylhydrazine in rats. Vopr Onkol 43: 618–622
Awara WM, El-Gohary M, El-Nabi SH, Fadel WA (1998) In vivo and in vitro evaluation of the muta¬genic potential of carbamazepine: does melatonin have anti-mutagenic activity? Toxicology 125: 45–52
Balanski R, Blagoeva P, Mircheva Z, Pozharisski K, de Flora S (1992) Effect of metabolic inhibitors, methylxanthines, antioxidants, alkali metals, and corn oil on 1,2-dimethylhydrzine carcinogenicity in rats. Anticancer Res 12: 933–940
Bandaletova TY (1990) Concerning primary development of 1,2-dimethyl-hydrazine-induced cancer in lymphoid patches of the large bowel. Vopr Onkol 36: 1456–1460
Barlow-Walden LR, Reiter RJ, Abe M, Pablos M, Menendez-Pelaez A, Chen LD, Poeggeler B (1995) Melatonin stimulates brain glutathione peroxidase activity. Neurochem Int 26: 497–502
Barni S, Lissoni P, Cazzaniga M, Ardizzoia A, Mergalli S, Fossati V, Fumagalli L, Brivio F, Tancini G (1995) A randomized study of low-dose subcutaneous interleukin-2 plus melatonin versus supportive care alone in metastatic colon cancer patients progressing under 5-fluorouracil and folates. Oncology 52: 243–245
Bartsch C, Bartsch H, Lippert TH (1992) The pineal gland and cancer: facts, hypotheses and perspectives. The Cancer J 5: 194–199
Bartsch C, Kvetnoy I, Kvetnaya T, Bartsch H, Molotkov A, Franz H, Raikhlin N, Mecke D (1997) Noc¬turnal urinary 6-sulfatoxymelatonin and proliferating cell nuclear antigen-immunopositive tumor cells show strong positive correlations in patients with gastrointestinal and lung cancer. J Pineal Res 23: 90–96
Bedi A, Pasricha PJ, Akhtar AJ, Barber JP, Bedi GC, Giardiello FM, Zehnbauer BA, Hamilton SR, Jones RJ (1995) Inhibition of apoptosis during development of colorectal cancer. Cancer Res 55: 1811–1816
Berstein LM (1995) The endocrinology of large bowel cancer. Endocrine-Related Cancer 2: 171–185
Blask DE (1993) Melatonin in oncology. In: Yu HS and Reiter RJ (eds) Melatonin Biosynthesis, Physiological Effects, and Clinical Applications. CRC Press, Boca Raton, pp 447–475
Bubenik GA (1999) Localization and physiological significance of gastrointestial melatonin. In: Watson RR (ed) Melatonin in Health Promotion. CRC Books, Boca Raton, pp 21–39
Cagnoli CM, Atabay C, Kharlamova E, Manev H (1995) Melatonin protects neurons from singlet oxygen-induced apoptosis. J Pineal Res 18: 222–226
Callaghan BD (1995) The long-term effect of pinealectomy on the crypts of the rat gastrointestinal tract. J Pineal Res 18: 191–196
Coleman MP, Esteve J, Damiecki P, Arslan A, Renard H (1993) Trends in Cancer Incidence and Mortality. IARC Sci Publ 121: 1–806
Dilman VM, Anisimov VN (1979) Hypothalamic mechanisms of ageing and of specific age patho-logy - I. Sensitivity threshold of hypothalamo-pituitary complex to homeostatic stimuli in the reproductive system. Exp Gerontol 14: 161–174
Dilman VM, Sofronov BN, Anisimov VN et al. (1977) Withdrawal of 1,2-dimethylhydrazine-induc-ed immunodepression by phenformin in rats. Vopr Onkol 23: 50–54
Hirose Y, Yoshimi N, Suzui M, Kawabata K, Tanaka T, Mori H (1997) Expression of bcl-2, bax, and bcl-XL proteins in azoxymethane -induced rat colonic adenocarcinomas. Mol Carcinogenesis 19: 25–30
Koratkar R, Vasudha A, Ramesh G et al. (1992) Effect of melatonin on cis-platinum induced genetic damage to the bone marrow cells of mice. Med Sei Res 20: 179–180
Kothari L, Subramanian A (1992) A possible modulatory influence of melatonin on representative phase I and II drug metabolizing enzymes in 9,10-dimethyl-l,2-benzanthracene induced rat mammary tumorigenesis. Anti-Cancer Drugs 3: 623–628
Kovalenko RI, Novikova I A, SibarovDA et al. (1998) Adaptive morphofunctional changes of pineal cells during tumor process in large intestine. Pathophysiology 5 (Suppl 1): 17
Kvetnoy IM, Levin IM (1987) Diurnal melatonin excretion in stomach and colon cancer patients. Vopr Onkol 33: 29–32
Kvetnoy I, Sandvik AK, Waldum HL (1997) The diffuse neuroendocrine system and extrapineal melatonin. J Mol Endoer 18: 1–3
Lewczuk B, Przybylska-Gornowicz B (1997) Effects of sympathicolytic and sympathicomimetic drugs on pineal ultrastructure in the domestic pig. J Pineal Res 23: 198–208
Lewinski A, Rybicka I, Wajs E, Szkudlinski M, Pawlikowski M (1991) Influence of pineal indola- mines on the mitotic activity of gastric and colonic mucosa epithelial cells in the rat: interaction with omeprazole. J Pineal Res 10: 104–108
Maskens AP (1987) Multistep carcinogenesis in the colorectal mucosa. In: Maskens AP, Ebbesen P, Burny A (eds) Concepts and Theories in Carcinogenesis. Excerpta Medica, Amsterdam, pp 221–242
Musatov SA, Anisimov VN, Andre V, Vigreux C, Godard T, Gauduchon P, Sichel F (1998) Modulatory effects of melatonin on genotoxic response of reference mutagens in the Ames test and the COMET assay. Mutat Res 417: 75–84
Musatov SA, Rosenfeld SV, Togo EF, Mikheev VS, Anisimov VN (1997) The influence of melatonin on mutagenicity and antitumor action of cytostatic drugs in mice. Vopr Onkol 43: 623–627
Neri B, De Leonardis V, Gemelli MT, di Loro F, Mottola A, Ponchietti R, Raugei A, Cini G (1998) Melatonin as biological response modifier in cancer patients. Anticancer Res 18: 1329–1332
Okulov VB, Pozharisski KM (1975) Carcinoembryonic antigen in experimental intestinal tumours. Bull Exp Biol Med 80: 78–81
Panzer A, Viljoen M (1997) The validity of melatonin as an oncostatic agent. J Pineal Res 22: 184–202
Pentney P (1995) An investigation of melatonin in the gastrointestinal tract. PhD Thesis, University of Guelph, pp 1–161
Petrelli C, Moretti P, Petrelli F, Bramucci M (1992) A low molecular weight calf pineal peptide with an inhibiting effect on the growth of L1210 and HL60 cells. Cell Biol Int Rep 16: 967–974
Pierrefiche G, Topall G, Courboin G, Henriet I, Laborit H (1993) Antioxidant activity of melatonin in mice. Res Commun Chem Pathol Pharmacol 80: 211–223
Pozharisski KM, Anisimov VN (1975) On the role of endocrine system in development of experi¬mental colon tumors in rats. Pathol Physiol 1: 47–50
Pozharisski KM, Likhachev AJ, Klimashevski VF, Shaposhnikov JD (1979) Experimental intestinal cancer research with special reference to human pathology. Adv Cancer Res 30: 165–237
Reiter RJ, Carneiro RC, Oh C-S (1997) Melatonin in relation to cellular antioxidative defense mechanisms. Horm Metab Res 29: 363–372
Reyes-Vazquez C, Prieto-Gomez B, Aides LD, Dafny N (1986) Rat pineal exhibits two electro¬physiological patterns of response to microiontophoretic norepinephrine application. J Pineal Res 3: 213–222
Roos JS (1992) Experimental large intestinal adenocarcinoma induced by hydrazine and human colorectal cancer: a comparative study. In: Malt RA, Williamson RCN (eds) Colon Carcinogenesis. Proc. of 31st Falk Symp, Titisee Lancaster, pp 187–210
Salim AS (1993) The permissive role of oxygen-derived free radicals in the development ot colonic cancer in the rat. A new theory for carcinogenesis. Int J Cancer 53: 1031–1035
Samaha HS, Kelloff GJ, Steele V, Rao CV, Reddy BS (1997) Modulation of apoptosis by sulindac, curcumin, phenylethyl-3-methylcaffeate, and 6-phenylhexyl isothiocyanate: apoptotic index as a biomarker in colon cancer chemoprevention and promotion. Cancer Res 57: 1301–1305
Semm P, Schneider T, Vollrath L (1981) Morphological and electrophysiological evidence for habenular influence on the guinea-pig pineal gland. J Neural Transm 50: 247–266
Shimamoto F, Vollmer E (1987) Changes in intestinal mucosa above lymph follicles during carcinogenesis in rats. A light and electron microscopic study. J Cancer Res Clin Oncol 113: 41–50
Steele G, Sjogren HO (1974) Cross-reacting tumor-associated antigen(s) among chemically induced rat colon carcinomas. Cancer Res 34: 1801–1807
Susa N, Ueno S, Furukawa Y, Ueda J, Sugiyama M (1997) Potent protective effect of melatonin on chromium(VI)-induced DNA single-strand breaks, cytotoxicity, and lipid peroxidation in primary cultures of rat hepatocytes. Toxicol Appl Pharmacol 144: 377–384
Tan D, Reiter RJ, Chen L, Poeggeler B, Manchester LC, Barlow-Waiden LR (1994) Both physiological and pharmacological levels of melatonin reduce DNA adduct formation induced by the carcinogen safrole. Carcinogenesis 15: 215–218
Tendier Y, Ben-Hur H, Gurevich P, Berman V, Sandler B, Nyska A, Zion H, Zinder O, Zusman I (1997) Role of apoptosis, proliferating cell nuclear antigen and p53 protein in the immune response of the rat colon cells to cancer and vaccination with the anti-p53 polyclonal antibodies. Anticancer Res 17: 4653–4658
Ubeda A, Trillo MA, House DE, Blackman CF (1995) Melatonin enhances junctional transfer in normal C3H/10T1/2 cells. Cancer Lett 91: 241–245
Vijayalaxmi, Reiter RJ, Leal BZ, Meltz ML (1996) Effect of melatonin on mitotic and proliferation indices, and sister chromatid exchange in human blood lymphocytes. Mutat Res 351: 187–192
Windle R, Bell PRF (1982) Lipid clearance in a colonic tumour model in rats. Br J Cancer 46: 515
Yu HS, Reiter RJ (eds) (1993) Melatonin Biosynthesis, Physiological Effects, and Clinical Applications. CRC Press, Boca Raton
Zusman I (1997) The role of p53 tumor-associated protein in colon cancer detection and preven¬tion (review). Int J Oncol 10: 1241–1249
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2001 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Anisimov, V.N. (2001). Melatonin and Colon Carcinogenesis. In: Bartsch, C., Bartsch, H., Blask, D.E., Cardinali, D.P., Hrushesky, W.J.M., Mecke, D. (eds) The Pineal Gland and Cancer. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-59512-7_11
Download citation
DOI: https://doi.org/10.1007/978-3-642-59512-7_11
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-64003-2
Online ISBN: 978-3-642-59512-7
eBook Packages: Springer Book Archive